LBA
CBIO

Letko, Brosseau & Associates’s Crescent Biopharma CBIO Stock Holding History

Letko, Brosseau & Associates’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-453
Closed -$12.7K – 104
2024
Q2 		$12.7K Hold
453
– – ﹤0.01% 103
2024
Q1 		$136K Hold
453
– – ﹤0.01% 99
2023
Q4 		$107K Hold
453
– – ﹤0.01% 92
2023
Q3 		$67.9K Hold
453
– – ﹤0.01% 96
2023
Q2 		$78.7K Hold
453
– – ﹤0.01% 92
2023
Q1 		$57K Buy
+453
New +$102K ﹤0.01% 88

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return